India’s drug regulator has begun drafting new guidelines for high-risk solvents used in children’s medicines, after deaths tied to contaminated cough syrups. Investigators reportedly found the solvents can carry toxic impurities. The regulator is consulting pharmaceutical companies to review current solvent practices and push safer alternatives, a move aimed at preventing further tragedies involving Indian-made syrups.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
